Sabrina Johnson | President and Chief Executive Officer |
Lisa Hoffert | Chief Financial Officer |
John Fair | Chief Business Officer |
Caroline Palomeque | Maxim Group |
Carol Werther | Dawson James |
Brian Marckx | Zacks Investment Research |
Welcome to the conference call hosted by Daré Bioscience to provide Financial Results For the Quarter Ended September 30, 2018, and a General Business Update. This call is being recorded. My name is Joele, and I’ll be your operator today. With us today are Sabrina Johnson, Daré’s Chief Executive Officer; Lisa Hoffert, Daré’s Chief Financial Officer; and John Fair, Daré’s Chief Business Officer. Miss Johnson, please proceed.